Auro Labs.

62
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
271.40
6.85 (2.59%)
BSENSE

Feb 06

BSE+NSE Vol: 15.82 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -63.83% vs 1.40% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -68.10% vs 142.90% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 47.13% vs -9.64% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -76.40% vs 219.09% in Mar 2024

Compare Profit and Loss Results of Auro Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
19.00
167.00
-148.00
-88.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
19.00
167.00
-148.00
-88.62%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
-1.00
5.00
500.00%
Raw Materials Consumed
5.00
85.00
-80.00
-94.12%
Power & Fuel Cost
0.00
15.00
-15.00
-100.00%
Employee Cost
2.00
13.00
-11.00
-84.62%
Operating Expenses
0.00
13.00
-13.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
14.00
-13.00
-92.86%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
1.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
15.00
148.00
-133.00
-89.86%
Operating Profit (PBDIT) excl Other Income
3.00
19.00
-16.00
-84.21%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
4.00
23.00
-19.00
-82.61%
Interest
1.00
6.00
-5.00
-83.33%
Profit before Depriciation and Tax
2.00
17.00
-15.00
-88.24%
Depreciation
1.00
8.00
-7.00
-87.50%
Profit Before Taxation & Exceptional Items
1.00
9.00
-8.00
-88.89%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
9.00
-8.00
-88.89%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
1.00
6.00
-5.00
-83.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
35.00
81.00
-46.00
-56.79%
Profit Available for appropriations
36.00
87.00
-51.00
-58.62%
Appropriations
36.00
87.00
-51.00
-58.62%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.95
6.43
-3.48
-54.12%
Profit And Loss - Net Sales
Net Sales 19.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -63.83% vs 1.40% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -68.10% vs 142.90% in Mar 2024

Profit And Loss - Interest
Interest 1.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 47.13% vs -9.64% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -76.40% vs 219.09% in Mar 2024